QIAGEN Biomedical KB-HD: data- and... (53:18)
Ingenuity Pathway Analysis (IPA), currently cited in tens of...
|
Integrating deeply curated omics data with APIs... (01:00:20)
This webinar is for data scientists and bioinformaticians who need...
|
Leveraging expert-curated knowledge from COSMIC... (45:16)
The cancer drug discovery landscape is shifting. While research...
|
Biomarker discovery, target validation, and... (01:27:15)
In this webinar, users will learn how to leverage solutions from...
|
Target exploration and cell line selection for... (01:31:11)
Cancer cell line models have been a cornerstone of cancer research...
|
Mining curated knowledge graphs and validating... (59:42)
In an era of near-limitless public experimental data but little...
|
Exploring pan-cancer immunomodulators for... (01:24:07)
Cancer outcome is influenced by both the tumor microenvironment and...
|
Cross-species comparison and validation for... (01:24:32)
Some human studies may be unfeasible or unethical, making...
|
Indication Expansion and Repurposing of PIK3CA... (24:12)
|
Drug treatment, toxicology and target safety... (01:29:57)
In this 90-minute training, you'll learn how to perform drug...
|
Interpreting genetic risk loci from GWAS in the... (01:32:42)
Genome-wide association studies (GWAS) provide insights into the...
|
Indication expansion and drug repurposing using... (01:38:10)
Research and development for new drugs and disease treatments can...
|
